CYPRESS Efficacy and Safety Study Extension
NCT: NCT04947735 · ACTIVE_NOT_RECRUITING
NCT IDNCT04947735
StatusACTIVE_NOT_RECRUITING
Start Date2021-07-19
Completion2026-12-31
Brief Summary
This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
Frequently Asked Questions
What is CYPRESS Efficacy and Safety Study Extension?
CYPRESS Efficacy and Safety Study Extension is a clinical trial registered under NCT04947735. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04947735?
The current status of NCT04947735 (CYPRESS Efficacy and Safety Study Extension) is: ACTIVE_NOT_RECRUITING.
When did CYPRESS Efficacy and Safety Study Extension start?
CYPRESS Efficacy and Safety Study Extension started on 2021-07-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.